Neumora Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Neumora Therapeutics stock have a consensus rating of "Buy" and an average price target of $6.57, which forecasts a 214.35% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $14.

Price Target: $6.57 (+214.35%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$6.57	$7.00	$14
Change	-52.15%	+214.35%	+234.93%	+569.86%

Analyst Ratings

The average analyst rating for Neumora Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	3	3	3	3	3	2
Buy	1	1	2	3	4	4
Hold	2	2	1	1	1	1
Sell	2	2	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	8	8	8	9	10	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Reiterates $14	Strong Buy	Reiterates	$14	+569.86%	Mar 31, 2026
Ami Fadia Needham	Needham	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+282.78%	Mar 31, 2026
Myles Minter William Blair	William Blair	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Feb 17, 2026
Marc Goodman Leerink Partners	Leerink Partners	Buy Initiates $8	Buy	Initiates	$8	+282.78%	Jan 12, 2026
Brian Abrahams RBC Capital	RBC Capital	Hold → Buy Upgrades $4 → $7	Hold → Buy	Upgrades	$4 → $7	+234.93%	Dec 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

8.08M

EPS This Year

-1.05

from -1.45

EPS Next Year

-1.03

from -1.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	8.08M
Revenue Growth	-	-	-	-	-	-	-
EPS	-10.84	-4.81	-3.63	-1.53	-1.45	-1.05	-1.03
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	21.0M
Avg	n/a	8.1M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.82	-0.49
Avg	-1.05	-1.03
Low	-1.42	-1.47

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.